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Abstract: Background and Objectives: Pre-term premature rupture of membranes (PPROM) responds
for one third of preterm births, and it is associated with other complications that increase the risk of
maternal or fetal poor outcome. To reduce uncertainty and provide accurate information to patients,
the analysis of the large series is of great importance. In order to learn about the evolution over
the time of the obstetric and perinatal outcomes in cases of PPROM at, or before, 28 weeks (very
early PPROM) managed with an expectant/conservative protocol, we have designed the present
study. Materials and Methods: We retrospectively studied all cases of very early PPROM attended in
Malaga University Regional Hospital from 2000 to 2020. Results: Among 119,888 deliveries assisted,
592 cases of PPROM occurred in pregnancies at or before 28 weeks (0.49% of all deliveries, 3.9%
of all preterm births and 12.9% of all cases of PPROM). The mean duration of the latency period
between PPROM and delivery was 13.5 days (range 0 to 88 days), enlarging over the years. The
mean gestational age at delivery was 27 weeks (SD 2.9; range 17–34). The proportion of cesarean
deliveries was 52.5%. The overall perinatal mortality rate was 26.5%, decreasing over the period with
a significant correlation Pearson’s coefficient −0.128 (p < 0.05). Conclusions: In the period 2000–2020,
there was an improvement in the outcomes of very early PPROM cases and perinatal mortality
showed a clear trend to decrease.
Keywords: very early PPROM; perinatal mortality; premature birth
1. Introduction
Pre-term premature rupture of fetal membranes (PPROM) complicates 2–3% of all
pregnancies [1]; responds for one third of all cases of preterm birth [2]; and it is associated
with secondary complications, which increase the risk of maternal or fetal poor outcome,
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like placental abruption, cord prolapse and intraamniotic infections [3]. The etiology of
PPROM remains unknown in most cases, and some genetic, environmental, mechanical,
microbiological and inflammatory factors have been described [4]. It is accepted that
preterm uterine contractions or mechanical distention of fetal membranes increase the risk
of PPROM [5]. Also, the prevalence of microbial invasion of the amniotic cavity has been
reported in half of the cases of PPROM [6], pointing out the role of microbial involvement;
and some genetic predisposition regarding polymorphism of MMP-2 has been described
to be associated with a higher rate of PPROM [7].
Most neonatal short- and long-term complications in cases of PPROM are predicted by
gestational age at delivery [8–10]. The prolongation of pregnancy needs to be considered
the primary goal of expectant management when infection is not present [8], especially in
very early onsets. In these cases, a careful balance between maternal and neonatal risks is
needed since a prolonged latency period between PPROM and delivery improves neonatal
outcomes, but it could also increase the risk of chorioamnionitis [11,12]. The perinatal
mortality figures associated with very early PPROM (at or before 28 weeks) are high [13,14],
but in recent years, some studies have demonstrated that outcomes for neonates delivered
following very early PPROM may be better than previously expected [10]. Although the
long-term neurodevelopmental outcomes after PPROM will depend on the interaction
between gen-environment, and the etiology of some central nervous system injuries that
can be found in some children born after very early PPROM remain unclear [8], the short-
term benefits of an expectant and conservative management are well established. In fact,
we could previously report in our setting [15] an encouraging upward trend in the duration
of latency period over the first decade of this century, and a decrease in perinatal mortality
associated with PPROM very far from term.
In order to learn about the evolution over the time of the obstetric and perinatal
outcomes in cases of very early PPROM managed with an expectant/conservative protocol,
we have designed the present study. Our goal was to review perinatal survival in cases of
very early PPROM attended in our maternity from 2000 to 2020, analyzing the temporal
trends of variables such as length of latency period, g.a. at delivery, mode of delivery,
obstetric complications (cord prolapse, chorioamnionitis and placental abruption) and
perinatal survival.
2. Materials and Methods
2.1. Study Design and Patients
We reviewed clinical records for cases of PPROM at or before 28 weeks admitted to
our obstetric department between 1 January 2000 and 31 December 2020.
After we obtained institutional authorization, we revised Andalusian case mix (mini-
mum basic data set registry) [16] to identify the records with diagnostic codes of PPROM
at or before 28 weeks. Once all the cases were identified, we reviewed the medical records
for information concerning the length of latency period, mode of delivery, gestational age
and obstetric complications as chorioamnionitis, cord prolapse or placental abruption. The
perinatal mortality data were obtained from the perinatal database of Neonatology and
Obstetrics Departments, identifying newborns delivered alive and admitted to the inten-
sive care unit until they were discharged or died. This database also included stillbirths.
Extended perinatal mortality was considered, i.e., intrauterine fetal demises from 22 weeks
g.a. and neonatal deaths until 28th day of life after delivery.
2.2. Statistical Analysis
Statistical analysis was performed using IBM SPSS Statistics v24 software. The Chi
square test was used to compare qualitative variables, and the t-test or ANOVA were used
to compare means between groups according to the number of categories of each variable,
always after confirming the normality of the distribution. We used Pearson’s coefficient for
correlations, and the area under the curve (AUC) analysis to predict the survival probability
of fetuses according to the gestational age at diagnosis.
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The data were treated statistically as a whole, aggregate per year and per g.a. at
PPROM, with the exception of those pregnancies with pre-viable g.a. at PPROM (before
240/7 weeks) that were considered as a distinct group.
2.3. Instruments
In the years of study an expectant-conservative management in cases of PPROM was
followed. All patients were hospitalized after diagnosis. A complete bed rest regimen was
advised in order to avoid amniotic fluid leakage and cord prolapse. We used prophylactic
antibiotics (simultaneous regimen of Ampicillin and Erythromycin for one week), a single
course of steroids (betamethasone 12 mg) when g.a. > 240/7 weeks, and tocolitycs (atosiban)
during 48 h if contractions were noted. After admission amniotic fluid samples were also
taken for conventional aerobic cultures (antibiotic regimen was modified according to the
bacterial resistances), and leucocytes and Reactive C Protein (CRP) were assessed every
48 h. If clinically stable, women with pre-viable PPROM (the edge of viability [17] was
established at 240/7 weeks), could leave the hospital until viability was reached if they
desired, following weekly ambulatory leukocytes and CRP controls. Over the 21 years of
study, only a few cases underwent ambulatory management until viability and almost all
women chose to remain hospitalized.
In the absence of complications either induction of labor or cesarean delivery for
obstetric indications were performed in g.a. > 340/7. When PPROM occurred before g.a.
220/7 weeks, the patient could request legal termination.
The amniotic fluid sampling for culture was extended to Mycoplasma, Chlamydia
and anaerobes search in 2006. Prophylactic antibiotic regimen was modified according to
the bacterial resistances observed in antibiograms [18]. The clinical diagnosis of chorioam-
nionitis were made according to Gibbs’ clinical and biological criteria [19], and in all
cases there was histological confirmation. Gibbs’ clinical criteria for chorioamnionitis
included temperature of at least 37.8 ◦C, and two or more of the following: Maternal
tachycardia, fetal tachycardia, uterine tenderness, foul odor of the amniotic fluid and
maternal leukocytosis. In cases of suspected chorioamnionitis that did not meet Gibb’s
criteria, amniocentesis was performed to confirm intraamniotic infection if low levels of
glucose, positive Gram-straining or microbiological cultures were found in the amniotic
fluid analysis.
In cases of extremely pre-viable PPROM we included those cases in which patients
chose to continue with the pregnancy and therefore the protocol of conservative manage-
ment was adopted. This means the loss of those other cases in which patients chose the
legal termination of pregnancy, where the follow-up was more difficult given that most of
the cases were discharged to be sent to specific clinics to undergo termination.
2.4. Ethics
The study was conducted in accordance with the Declaration of Helsinki, and the pro-
tocol (ecarpmp) was approved on 12 July 2016 by the reference Research Ethics Committee.
3. Results
From 1 January 2000 to 31 December 2020 a total of 119,888 deliveries were assisted in
Malaga University Regional Hospital. Among them, 14,931 were under 37 weeks, and 4591
cases of PPROM were diagnosed. These represented 3.8% of all deliveries attended and
30.7% of all preterm births. A total of 592 (0.5% of all deliveries, 3.9% of all preterm births
and 12.9% of cases all of PPROM) occurred in pregnancies at, or before, 28 weeks (very
early PPROM). The prematurity rates and the perinatal mortality rates from 2000 to 2020 in
our maternity are shown in Figure 1.




Figure 1. Perinatal mortality (‰) and prematurity rates (%) per year of study. 
The distributions of the 592 cases of very early PPROM per year and g.a. at diagnosis 
are shown in Figure 2. Mean maternal age in the period was 31.5 years, with a clear trend 
to increase over the years (r = 0.14, p < 0.001), so that mean maternal age was 2.4 years 
higher in the period 2015–2020 when compared with the first five-years period (32.8 
against 30.4 years, p < 0.01). We also found a negative correlation between the mean age 
of the participants and the gestational age at PPROM diagnosis (r = −0.12; p < 0.01). 
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In this population (n = 592), 64 placental abruption (10.8%), 112 clinical chorioam-
nionitis (18.9%) and 9 cord prolapse (1.5%) were diagnosed during hospital admission, so
that it was necessary to deliver urgently regardless of g.a. It should be noted that 19 cases
(3.2%) were carriers of cervical cerclage and 60 cases (10.1%) needed the use of tocolytics
(i.v. atosiban for 48 h). In the pre-viable group, cesarean sections were performed only for
maternal indications (severe medical conditions or prior uterine surgery). The proportion
of cesarean deliveries was 52.5%. No differences were observed over the years, but cesarean
deliveries were significantly more frequent when g.a. at delivery was higher (p < 0.001)
(Figure 3). We did not find any significant relationship between maternal age and the
duration of latency period between PPROM and delivery, the appearance of complications,
or the type of delivery.
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Mean latency values between PPROM and delivery for the periods 2000–2005, 2006–
2010, 2011–2015 and 2016–2020 were 10.1, 12.8, 16.8, and 12.9, respectively (Figure 5).
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Figure 5. Mean latency period between PPROM and delivery in groups of gestational age at PPROM diagnosis.
We have observed a decreased in the duration of the latency period between PPROM
and delivery during the last five-year period. According to g.a. at PPROM diagnosis, a
significant reduction of the latency between PPROM and delivery has been found in the
group of pre-viable PPROM, in the second half of the last decade (mean difference between
the periods 2011–2015 and 2016–2020 = 8.3 days, SD 3.7; p < 0.01).
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A significant correlation between the duration of the latency period between PPROM
and delivery and the year of study was found in the period 2000–2010 (Pearson’s coefficient
= 0.148; p < 0.01), but not within the period from 2011 to 2020. In the group of previable
PPROM, a clear trend towards the prolongation of latency between PPROM and delivery
was observed since 2005, so that in 2009 and 2010 more than half of patients with PPROM
before 240/7 weeks reached viability, and in 2010 one out of three exceeded 28 weeks. This
trend decreased during the period 2016–2020, so that in the last year of observation (2020),
only the 39.9% of pre-viable PPROM reached viability (7/18), and none of them reached
28 weeks (Figure 6).
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ft r s tf l days following the diagnosis, the probability to deliver at 26 or
28 weeks of g.a. was 54.5%, or 45.9%, respectively, and 76.4% or 62.3% after 14 days of
latency (ROC curves at Figure 7).
When pre-viable PPROM occurred before 17, 20 or 22 weeks the probability to deliver
over the 28 weeks g.a. was 6%, 26.7%, and 65.8% respectively, and 6.5%, 27.6% and 66.7%
to deliver at least at 26 weeks g.a.
The overall perinatal mortality rate was 26.5%, decreasing over the period, and
showing a significant correlation Pearson´s coefficient −0.128 (p < 0.05). Neonatal deaths
accounted for 58.7% of the whole perinatal mortality, and fetal mortality was 42.3%. While
in the first decade the rate was as high as 30.6%, in the period from 2011 to 2020 it was
22.3% (Figure 8).
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The duration of the latency period from diagnosis until delivery correlated signif-
icantly with perinatal mortality (Pearson’s coefficient 0.234; p < 0.0001). However, the
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(21/83), 22.6% (17/75), 10.6% (8/75) and 7.75% (9/116) in cases of PPROM at 24, 25, 26, 27,
and 28 weeks, respectively.
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perinatal mortality rates associated with this complication, as well as the prolongation of 
the latency period until delivery over the years. However, some fluctuations have been 
observed throughout the whole period, but a clear trend towards the improvement is en-
sured, we must be aware of the increase in the mortality figures found in the last five 
years, specifically in the group of pre-viable PPROM in which perinatal deaths reached 
42%, nine points over the rate observed in the period 2011–2015. This increase is mainly 
due to the number of deaths registered during the last two years of the period greater than 
those observed before (28% in 2017, 20% in 2018, 35% in 2019 and 36.5% in 2020). We do 
not have a clear explanation for this increase because there were no changes in the man-
agement of these pregnancies, except for some necessary changes in the staff who pro-
vided care in the obstetric ward, and for all the organizational changes in the obstetric 
ward due to the COVID-19 pandemic during 2020. The pandemic produced some changes 
in the obstetric care, due to the need for hospital beds to admit patients with Covid-19, 
and to the effects of the pandemic on the hospital staff. These changes could have influ-
enced the results. 
At present, it is clear enough that the use of prophylactic antibiotics is beneficial for 
newborns and their mothers. It has been shown a prolongation of the latency period, a 
decrease in diagnoses of chorioamnionitis, neonatal respiratory distress and sepsis [20,21]. 
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This paper shows the obstetric outcomes and perinatal mortality rates in a large
sample of pregnancies complicated with very early PPROM admitted at alaga University
Regional Hospital during the period 2000–2020. e confirmed the decreasing trend in the
perinatal mortality rates associated with this complication, as well as the prolongation of
the latency period until delivery over the years. However, some fluctuations have been
observed throughout the whole period, but a clear trend towards the improvement is
ensured, we must be aware of the increase in the mortality figures found in the last five
years, specifically in the group of pre-viable PPROM in which perinatal deaths reached
42%, nine points over the rate observed in the period 2011–2015. This increase is mainly
due to the number of deaths registered during the last two years of the period greater
than those observed before (28% in 2017, 20% in 2018, 35% in 2019 and 36.5% in 2020).
We do not have a clear explanation for this increase because there were no changes in the
management of these pregnancies, except for some necessary changes in the staff who
provided care in the obstetric ward, and for all the organizational changes in the obstetric
ward due to the COVID-19 pandemic during 2020. The pandemic produced some changes
in the obstetric care, due to the need for hospital beds to admit patients with Covid-19, and
to the effects of the pandemic on the hospital staff. These changes could have influenced
the results.
At present, it is clear enough that the use of prophylactic antibiotics is beneficial for
newborns and their mothers. It has been shown a prolongation of the latency period, a
decrease in diagnoses of chorioamnionitis, neonatal respiratory distress and sepsis [20,21].
In our Hospital the ORACLE II study provided consistency in antibiotic treatments for
PPROM, subjected to some variability until 2003 [22]. Benefits arising the use of cor-
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ticosteroids to accelerate fetal lung maturation and reduce the risk of necrotizing ente-
rocolitis and intraventricular hemorrhage cases of PPROM over 240/7 weeks are also
important [23–25]. In our series, the latency period has been progressively extended over
the years. Actions, such as the homogeneity in antibiotic treatment promotion, periodical
sampling for amniotic fluid cultures and additional antibiotic courses in cases of isolation
of pathogens according to the antibiogram, have contributed to increase the latency pe-
riod until delivery. This reduces the effect of extreme prematurity in the figures perinatal
mortality associated to PPROM.
When PPROM complicates the pregnancy far from term, at pre-viable g.a., obstetri-
cians have to deal with the uncertainty that this condition entails. The lack of prospective,
randomized and controlled trials, and the variety of variables influencing neonatal and
maternal outcomes in cases of PPROM, means that clinicians have to deliver information
based on the results of retrospective studies with a limited number of cases. In order to
provide accurate information to these patients, the analysis of the results of large local
series is of great importance. In our experience, when the information includes encouraging
data, in terms of latency prolongation and survival rate of preterm newborns, women
often accept an active/expectant management with hospitalization, bed rest, antibiotics
and corticosteroids from g.a. 240/7 weeks. On the other hand, when the information is
limited to providing perinatal mortality and morbidity rates, women usually request legal
termination of the pregnancy.
In our maternity, the diagnosis of PPROM involves the patient’s institutionalization in
order to facilitate early diagnosis of possible chorioamniotic infection. We also recommend
bed rest, at least during the first days after diagnosis, to prevent loss of amniotic fluid and
cord prolapse. Although there is not enough evidence of the benefits of hospitalization,
bed rest [26,27] or amnioinfusion in patients with pre-viable PPROM [28–30], most of the
women with pre-viable PPROM opt for admission in the obstetric ward and bed rest. In
these cases, weight-adjusted daily doses of low-molecular-weight heparin are included in
the treatment.
All the data included in this paper provide valuable information to advance a fore-
cast about perinatal outcome after extremely PPROM diagnosis, being the largest sample
(592 cases) of very early PPROM that has been published in our country. However, its de-
sign has some limitations derived from the retrospective review of the clinical information
and the accuracy of the records. Over the years of study, some important changes in the
information and recording systems made it very difficult to gather homogeneous data sets
on sociodemographic and non-clinical variables, and only maternal age was available for
analysis as a cofactor. Also, this series only includes the cases of women with pre-viable
PPROM that opt for an active/expectant management, and not those who request legal
termination, whose records were not available.
5. Conclusions
We have confirmed a decreasing trend in the perinatal mortality rates associated with
PPROM, and a prolongation of the latency period until delivery over the years of study.
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